A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.

doi:10.1159/000355878

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes - 1 Jan 2014

Eun Y G, Chung D H, Kim S W, Lee Y C, Kim S K, Kwon K H

Abstract excerpt

PURPOSE: To determine whether a Fas-associated via death domain (FADD) promoter single-nucleotide polymorphism (SNP) is associated with susceptibility to papillary thyroid cancer (PTC) and clinicopathological features of PTC. METHODS: To identify a possible association with PTC, 94 patients with PTC and 346 healthy controls were recruited. One promoter SNP (rs10898853, -16C/T) was analyzed by direct sequencing....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma

Share to Carcinoma, Papillary

Share to Fas-Associated Death Domain Protein

Share to Promoter Regions, Genetic

Share to Republic of Korea

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed

Identifiers

PMID: 24434721
DOI: 10.1159/000355878

Genes

FADD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.PMID 24434721Read ↗

Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.Semantic proximity Read ↗

Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.Semantic proximity Read ↗

Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.Semantic proximity Read ↗

A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.Semantic proximity Read ↗

PDPR Gene Variants Predisposing to Papillary Thyroid Cancer.Semantic proximity Read ↗

Association of Fas -1377 G/A polymorphism with susceptibility to cancer.Semantic proximity Read ↗

Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis.Semantic proximity Read ↗

Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.Semantic proximity Read ↗

Association of IRAK1 Gene Polymorphism rs3027898 With Papillary Cancer Restricted to the Thyroid Gland: A Pilot Study.Semantic proximity Read ↗

Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.Semantic proximity Read ↗

Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.